Novartis Q2 2016 Results Investor Presentation

Novartis presents Q2 2016 financial and operational results covering group performance, financial review, and drug development updates. The presentation includes discussion of strategic restructuring initiatives announced in January 2016 to focus divisions and leverage scale across the organization.